MEDICAL ALLEY, Minn. (5/14/2024) — Today, Medical Alley® announced a new strategic partnership with Capita3, a deep tech healthcare venture capital firm, to accelerate innovation and investment within its global investor and corporate partner network.
Through this agreement, Medical Alley Starts® — a venture platform which accelerates the formation and growth of healthcare startups — will work with Capita3 to increase technology commercialization, startup launch opportunities, and financing of startups led by women healthcare experts.
“Our partnership with Capita3 underscores a shared commitment to shape the next generation of healthcare leaders,” Medical Alley President and CEO Roberta Dressen said. “Through this collaboration, we’ll expand our resources for deep tech startups developing innovations that are central to advancing a sustainable future of health.”
Capita3 is an early-stage venture capital group leveraging a decades-long healthcare innovation super cycle. This cycle is fueled by long-awaited advances in ‘deep tech’, which refers to foundational technologies and scientific breakthroughs.
“Medical Alley is the epicenter of an innovation super cycle and serves companies from across the healthcare ecosystem,” Capita3 Managing Partner Kathy Tune said. “In the last several years we have seen enormous changes in healthcare that coincide with rapid advances in data science and a maturing digital infrastructure. These trends are opening entirely new healthcare markets. We have collaborated with Medical Alley for years and are excited to strengthen our efforts at a key time when industry challenges have created fertile ground and an ideal backdrop for new business formation.”
As the Midwest ecosystem grows, Capita3 will continue in the strongest sectors, investing nationwide in areas of healthcare including data analytics, AI, advanced diagnostics, unique health care delivery approaches, and multi-omic health data as major themes across their portfolio.
Capita3 has also developed a human capital platform called Leader LaunchTM. This platform equips nontraditional founders with the integral skills to achieve critical business milestones and maximize leadership performance. Over 500 women have successfully participated to date. Capita3 has partnered with MNSBIR, Mayo Clinic, MATTER Health, the U.S. Small Business Administration (SBA) and others to provide programs across the US.
This strategic partnership marks the second Starts Venture Partner in 2024, joining Minnesota-based Bread and Butter Ventures in February. Medical Alley also announced a collaboration agreement with Mayo Clinic Platform in March.
Since the program’s inception in 2021, Medical Alley Starts has supported nearly 3,000 startups and annually engages 250 investment funds and 100 corporate strategics while delivering nearly $1 billion in value.
###
About Medical Alley®
Founded in 1984, Medical Alley leverages a global network of health technology and care organizations to drive innovation and accelerate the development of breakthrough healthcare solutions to benefit patients around the world. Our vision is to elevate the Medical Alley® region as the epicenter of health innovation and care™. To learn more, https://medicalalley.org/
About Capita3
Capita3 backs women-led emerging startups with breakthrough innovations at the intersection of tech and human health. Capita3 leads and catalyzes deals, taking active roles — including joining the board of directors in pre-seed and seed stage companies. With a passion for helping female founders succeed, the firm, built “Capita3 Leader Launch,” where participants significantly increase their ability to achieve critical business milestones. Capita3 is located in Minneapolis and Chicago and invests U.S.-wide, with a focus on Midwest ecosystem building for female founders.
